JP Morgan Chase
RPTP

JP Morgan Chase’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

JP Morgan Chase’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-519,632
Closed -$4.66M – 5354
2016
Q3 		$4.66M Buy
519,632
+70,223
+16% +$499K ﹤0.01% 2303
2016
Q2 		$2.41M Buy
449,409
+129,974
+41% +$666K ﹤0.01% 2708
2016
Q1 		$1.47M Sell
319,435
-25,465
-7% -$102K ﹤0.01% 2866
2015
Q4 		$1.79M Buy
+344,900
New +$2M ﹤0.01% 2808
2014
Q1 		– Sell
-22,765
Closed -$296K – 4257
2013
Q4 		$296K Sell
22,765
-700,994
-97% -$9.65M ﹤0.01% 3682
2013
Q3 		$10.8M Sell
723,759
-39,219
-5% -$470K ﹤0.01% 1718
2013
Q2 		$7.13M Buy
+762,978
New +$5.17M ﹤0.01% 1887

JP Morgan Chase's RPTP Position: Q4 2016 in Review

JP Morgan Chase sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 519,632 shares — an estimated $4.66M sold.

JP Morgan Chase first reported a position in RPTP in Q2 2013 and held it in 7 quarters. The position peaked at $10.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • JP Morgan Chase reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 519,632 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $4.66M.
  • JP Morgan Chase first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 7 quarters.
  • JP Morgan Chase's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $10.8M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.